BRCA1 and melanoma: However, with the exception of BRCA1, CDKN2A and CHEK1 which are known to enhance the cell cycle regulatory function of P53 [36,37], no other cofactors/regulators of P53 activity were altered in melanoma that could describe the lack of effect observed on P53 target genes as a result of P53 inhibition.